Antlia Bioscience, Inc.
PrivateLast Round
Seed Round
Jun 5, 2026
Total Funding Raised
$1.21M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Antlia Bioscience, Inc. is a biopharmaceutical company that develops peptide-based therapies for the treatment of cardiovascular and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antlia Bioscience, Inc. Comparables
Compare Antlia Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XL-protein | 76% | |
| Sanofi | 75% | |
| Vasa Therapeutics | 74% | |
Antlia Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 5, 2026 | ||||
| VC Round | Apr 25, 2022 | ||||
| Seed | Oct 23, 2020 |
Antlia Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
Raised $6M in a Seed Round.
- Oct 30, 2024
Monthly visitors grew 283% MoM, from 135 to 517.
Antlia Bioscience, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antlia Bioscience, Inc.'s valuation, stock price, and market status.